Literature DB >> 12975087

[Clinical utility of serous tumoural markers].

A Martín Suárez1, L Alonso Díaz, I Ordiz Alvarez, J Vázquez, F Vizoso Piñeiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12975087      PMCID： PMC7668714          DOI： 10.1016/s0212-6567(03)79257-9

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  73 in total

1.  Preoperative carbohydrate antigen 195 (CA195) and CEA serum levels as prognostic factors in patients with colorectal cancer.

Authors:  A Andicoechea; F Vizoso; E Alexandre; E Cuesta; M Cruz Díez; L Miera; J L García-Muñiz; E Martínez; A Ruibal
Journal:  Int J Biol Markers       Date:  1998 Jul-Sep       Impact factor: 2.659

Review 2.  Cell membrane-associated mucins and their adhesion-modulating property.

Authors:  J Hilkens; M J Ligtenberg; H L Vos; S V Litvinov
Journal:  Trends Biochem Sci       Date:  1992-09       Impact factor: 13.807

3.  Potential use of tumour marker CA 15-3 in the staging and prognosis of patients with breast cancer.

Authors:  J M Horobin; M C Browning; N P McFarlane; G Smith; P E Preece; R A Wood; A Cuschieri
Journal:  J R Coll Surg Edinb       Date:  1991-08

4.  A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.

Authors:  I Phocas; A Sarandakou; K Sikiotis; D Rizos; D Kalambokis; P A Zourlas
Journal:  Anticancer Res       Date:  1996 Nov-Dec       Impact factor: 2.480

5.  1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

6.  Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma.

Authors:  S G Shering; F Sherry; E W McDermott; N J O'Higgins; M J Duffy
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

7.  Evidence of a correlation between CA15.3 and estradiol serum levels in women with fibrocystic (non macrocystic) mastopathy.

Authors:  F Vizoso; M T Allende; M C Diez; A Ruibal
Journal:  Int J Biol Markers       Date:  1991 Jan-Mar       Impact factor: 3.248

8.  Evidence of a correlation between CA15.3 and prolactin serum levels after TRH administration in women with gross cystic breast disease.

Authors:  F Vizoso; M T Allende; A Fueyo; L Riera; C López Otin; A Ruibal
Journal:  Int J Biol Markers       Date:  1991 Jan-Mar       Impact factor: 3.248

Review 9.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis.

Authors:  M J Duffy; T M Maguire; A Hill; E McDermott; N O'Higgins
Journal:  Breast Cancer Res       Date:  2000-06-07       Impact factor: 6.466

10.  Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.

Authors:  S Kawa; M Tokoo; O Hasebe; K Hayashi; H Imai; H Oguchi; K Kiyosawa; S Furuta; T Homma
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640
View more
  1 in total

1.  [Clinical use of serum tumour markers].

Authors:  J Merino Montes; F Nogales Fernández; M M Olmedo Jiménez
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.